MannKind | MNKD - Market Capitalization


MannKind reported $740.9M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 3.52B 824M Mar/2026
BioCryst Pharmaceuticals USD 1.7B 40M Mar/2026
Eli Lilly USD 1.02T 293.84B Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Insmed USD 37.12B 6.68B Dec/2025
MacroGenics USD 192M 90M Mar/2026
MannKind USD 1.74B 93M Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Novavax USD 1.43B 340M Mar/2026
Pfizer USD 153.96B 12.4B Mar/2026
Sanofi EUR 100.88B 4.46B Dec/2025
Xencor USD 1.09B 256M Dec/2025